rCSP/AP10-602 [GLA-LSQ] Vaccine Trial

Clinical trial NCT03589794 · COMPLETED

Trial details

NCT number: NCT03589794
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Plasmodium Falciparum Infection

Start date: 2018-12-21
Primary completion: 2022-07-05
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.